Home
INSM
INSM News

Latest Insmed Incorporated (INSM) News on February 23, 2025

MT Newswires

2 days ago

UBS Adjusts Insmed Price Target to $105 From $84, Maintains Buy Rating

MT Newswires

2 days ago

Truist Securities Adjusts Insmed Price Target to $108 From $105, Maintains Buy Rating

Insmed's Q4 Loss Wider Than Expected, Sales In Line With Estimates

Zacks

2 days ago

Insmed's Q4 Loss Wider Than Expected, Sales In Line With Estimates

Insmed Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

2 days ago

Insmed Full Year 2024 Earnings: EPS Misses Expectations

Insmed Inc (INSM) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

GuruFocus.com

2 days ago

Insmed Inc (INSM) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

MT Newswires

2 days ago

Insmed Insider Sold Shares Worth $1,471,394, According to a Recent SEC Filing

MT Newswires

2 days ago

Insmed Insider Sold Shares Worth $2,072,721, According to a Recent SEC Filing

Insmed (INSM) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

3 days ago

Insmed (INSM) Reports Q4 Earnings: What Key Metrics Have to Say

MT Newswires

3 days ago

Sector Update: Health Care Stocks Flat to Lower Pre-Bell Thursday

Insmed (INSM) Reports Q4 Loss, Tops Revenue Estimates

Zacks

3 days ago

Insmed (INSM) Reports Q4 Loss, Tops Revenue Estimates

Associated Press Finance

3 days ago

Insmed: Q4 Earnings Snapshot

MT Newswires

3 days ago

Insmed's Q4 Loss Widens, Revenue Rises

Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update

PR Newswire

3 days ago

Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update

Will Insmed Incorporated’s (INSM) New Drugs be Able to Peak Sales?

Insider Monkey

4 days ago

Will Insmed Incorporated’s (INSM) New Drugs be Able to Peak Sales?

MT Newswires

5 days ago

Mizuho Adjusts Price Target on Insmed to $96 From $88, Keeps Outperform Rating

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

Zacks

6 days ago

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

Countdown to Insmed (INSM) Q4 Earnings: Wall Street Forecasts for Key Metrics

Zacks

6 days ago

Countdown to Insmed (INSM) Q4 Earnings: Wall Street Forecasts for Key Metrics

MT Newswires

9 days ago

Insmed Insider Sold Shares Worth $1,465,680, According to a Recent SEC Filing

Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Zacks

10 days ago

Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Insmed To Present at March 2025 Investor Conferences

PR Newswire

12 days ago

Insmed To Present at March 2025 Investor Conferences

Insmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025

PR Newswire

13 days ago

Insmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025

Argus Research

13 days ago

Daily – Vickers Top Buyers & Sellers for 02/10/2025

MT Newswires

15 days ago

Insmed Insider Sold Shares Worth $1,670,585, According to a Recent SEC Filing

MT Newswires

15 days ago

Insmed Insider Sold Shares Worth $2,296,751, According to a Recent SEC Filing

MT Newswires

15 days ago

Insmed Insider Sold Shares Worth $640,708, According to a Recent SEC Filing

MT Newswires

15 days ago

Insmed Insider Sold Shares Worth $6,419,415, According to a Recent SEC Filing

MT Newswires

15 days ago

Insmed Insider Sold Shares Worth $3,697,402, According to a Recent SEC Filing

MT Newswires

15 days ago

Insmed Insider Sold Shares Worth $1,901,150, According to a Recent SEC Filing

MT Newswires

15 days ago

Insmed Insider Sold Shares Worth $2,678,925, According to a Recent SEC Filing

Insmed's NDA for Lung Disease Drug Gets FDA's Priority Review

Zacks

16 days ago

Insmed's NDA for Lung Disease Drug Gets FDA's Priority Review

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire

16 days ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

MT Newswires

17 days ago

Insmed Says Brensocatib Application for Lung Disease Gets FDA Priority Review

FDA Grants Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis with PDUFA Target Action Date Set for August 12, 2025

PR Newswire

17 days ago

FDA Grants Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis with PDUFA Target Action Date Set for August 12, 2025

MT Newswires

17 days ago

Morgan Stanley Raises Price Target on Insmed to $90 From $85, Keeps Overweight Rating

MT Newswires

17 days ago

Insmed Insider Sold Shares Worth $1,993,731, According to a Recent SEC Filing

MT Newswires

22 days ago

Insmed Insider Sold Shares Worth $7,291,200, According to a Recent SEC Filing

Gene therapies have been uneven for DMD — but these companies hope to turn the tide

Pharma Voice

a month ago

Gene therapies have been uneven for DMD — but these companies hope to turn the tide

The five-year returns have been solid for Insmed (NASDAQ:INSM) shareholders despite underlying losses increasing

Simply Wall St.

a month ago

The five-year returns have been solid for Insmed (NASDAQ:INSM) shareholders despite underlying losses increasing

Is Insmed Incorporated (INSM) One of the Best Russell 2000 Stocks to Invest in According to Analysts?

Insider Monkey

a month ago

Is Insmed Incorporated (INSM) One of the Best Russell 2000 Stocks to Invest in According to Analysts?

MT Newswires

a month ago

Insmed Insider Sold Shares Worth $2,711,456, According to a Recent SEC Filing

Insmed’s gene therapy poised to challenge DMD landscape after IND clearance

Pharmaceutical Technology

a month ago

Insmed’s gene therapy poised to challenge DMD landscape after IND clearance

Why INSM Stock Is Advancing Today

Insider Monkey

a month ago

Why INSM Stock Is Advancing Today

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 01/13/2025

MT Newswires

a month ago

Insmed Says Full-year Revenue Expected to Rise 19%

Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire

a month ago

Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $1,786,644, According to a Recent SEC Filing

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire

2 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire

2 months ago

Insmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Why Is Insmed Incorporated (INSM) Among the Best Multibagger Stocks to Buy Right Now?

Insider Monkey

2 months ago

Why Is Insmed Incorporated (INSM) Among the Best Multibagger Stocks to Buy Right Now?

Is Insmed Incorporated (INSM) the Best Performing Biotech Stock in 2024?

Insider Monkey

2 months ago

Is Insmed Incorporated (INSM) the Best Performing Biotech Stock in 2024?

5 Biotech Breakthrough Stocks to Watch in 2025

Zacks

2 months ago

5 Biotech Breakthrough Stocks to Watch in 2025

Should You Invest in Insmed Incorporated (INSM)?

Insider Monkey

2 months ago

Should You Invest in Insmed Incorporated (INSM)?

Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?

Zacks

3 months ago

Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire

3 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report?

Zacks

3 months ago

Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report?

Why Is Insmed Incorporated (INSM) Among the Best High Growth Healthcare Stocks to Invest In Now?

Insider Monkey

3 months ago

Why Is Insmed Incorporated (INSM) Among the Best High Growth Healthcare Stocks to Invest In Now?

Insmed To Present at December 2024 Investor Conferences

PR Newswire

3 months ago

Insmed To Present at December 2024 Investor Conferences

MT Newswires

3 months ago

Sector Update: Health Care Stocks Decline

MT Newswires

3 months ago

Sector Update: Health Care Stocks Mixed Tuesday Afternoon

MT Newswires

3 months ago

Insmed Terminates $500 Million Share Sale Agreement With Leerink

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire

4 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed To Present at November 2024 Investor Conferences

PR Newswire

4 months ago

Insmed To Present at November 2024 Investor Conferences

Insmed (INSM) Reliance on International Sales: What Investors Need to Know

Zacks

4 months ago

Insmed (INSM) Reliance on International Sales: What Investors Need to Know

Do You Believe in the Growth Potential of Insmed (INSM)?

Insider Monkey

4 months ago

Do You Believe in the Growth Potential of Insmed (INSM)?

Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates

Zacks

4 months ago

Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates

Insmed Third Quarter 2024 Earnings: EPS Misses Expectations

Simply Wall St.

4 months ago

Insmed Third Quarter 2024 Earnings: EPS Misses Expectations

Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

4 months ago

Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Thomson Reuters StreetEvents

4 months ago

Q3 2024 Insmed Inc Earnings Call

Decoding Insmed Inc (INSM): A Strategic SWOT Insight

GuruFocus.com

4 months ago

Decoding Insmed Inc (INSM): A Strategic SWOT Insight

Insmed (INSM) Reports Q3 Earnings: What Key Metrics Have to Say

Zacks

4 months ago

Insmed (INSM) Reports Q3 Earnings: What Key Metrics Have to Say

MT Newswires

4 months ago

Insmed Q3 Net Loss Widens, Revenue Rises

Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates

Zacks

4 months ago

Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates

Associated Press Finance

4 months ago

Insmed: Q3 Earnings Snapshot

Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update

PR Newswire

4 months ago

Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update

Insmed (INSM) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Zacks

4 months ago

Insmed (INSM) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

How to play biotech stocks: Insmed and Wave Life Sciences

Yahoo Finance Video

4 months ago

How to play biotech stocks: Insmed and Wave Life Sciences

Insmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List

PR Newswire

4 months ago

Insmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

4 months ago

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?

Insmed Unites Across Communities Around the World During Third Annual Global Day of Good

PR Newswire

4 months ago

Insmed Unites Across Communities Around the World During Third Annual Global Day of Good

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

4 months ago

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024

PR Newswire

4 months ago

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024

MT Newswires

4 months ago

Truist Securities Raises Insmed's Price Target to $100 From $85, Buy Rating Maintained

Insmed Inc (INSM) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

GuruFocus.com

4 months ago

Insmed Inc (INSM) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains?

Zacks

4 months ago

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains?

MT Newswires

4 months ago

Insmed Reports Consistent Subgroup Data in Phase 3 Study of Brensocatib With Overall Trial Results

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results

PR Newswire

4 months ago

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now

Insider Monkey

5 months ago

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire

5 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Is Insmed Incorporated (INSM) the Best Performing Long Term Stock in 2024?

Insider Monkey

5 months ago

Is Insmed Incorporated (INSM) the Best Performing Long Term Stock in 2024?

Is Insmed Inc. (INSM) the Best Performing Stock in 2024?

Insider Monkey

5 months ago

Is Insmed Inc. (INSM) the Best Performing Stock in 2024?

Insmed Inc. (INSM): A Top Mid-Cap Biopharma Stock with Compelling Growth Potential

Insider Monkey

5 months ago

Insmed Inc. (INSM): A Top Mid-Cap Biopharma Stock with Compelling Growth Potential

MT Newswires

5 months ago

Insmed Insider Sold Shares Worth $3,074,177, According to a Recent SEC Filing

MT Newswires

5 months ago

Insmed Insider Sold Shares Worth $2,072,223, According to a Recent SEC Filing

Insmed Incorporated (INSM) Surged Following Positive Data For its Drug

Insider Monkey

5 months ago

Insmed Incorporated (INSM) Surged Following Positive Data For its Drug

Insmed Incorporated (INSM): Hedge Funds Are Recommending This Biotech Stock Now

Insider Monkey

5 months ago

Insmed Incorporated (INSM): Hedge Funds Are Recommending This Biotech Stock Now

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire

6 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed (INSM) Rose Due to Positive Trial Results

Insider Monkey

6 months ago

Insmed (INSM) Rose Due to Positive Trial Results

Insmed Stock Surges 168% in the Past Six Months: Here's Why

Zacks

6 months ago

Insmed Stock Surges 168% in the Past Six Months: Here's Why

Meta Stock Leads 5 Names Near Buy Points As Market Bounces

Investor's Business Daily

6 months ago

Meta Stock Leads 5 Names Near Buy Points As Market Bounces

MT Newswires

6 months ago

Mizuho Adjusts Price Target on Insmed to $92 From $82, Maintains Outperform Rating

Share on Social Networks: